# C_2016020EN.01000201.xml

| 21.1.2016 | EN | Official Journal of the European Union | C 20/2 |
| --- | --- | --- | --- |

21.1.2016

EN

Official Journal of the European Union

C 20/2

---

Prior notification of a concentration

(Case M.7818 — McKesson/UDG Healthcare (pharmaceutical wholesale and associated businesses))

(Text with EEA relevance)

(2016/C 20/02)

| 1. | On 14 January 2016, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which McKesson Deutschland GmbH & Co KGaA, an entity ultimately owned by the McKesson Corporation (‘McKesson’, United States) acquires certain businesses (‘the Target’) from UDG Healthcare plc (‘UDG’, Ireland), by way of purchase of shares. |
| --- | --- |

1.

On 14 January 2016, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which McKesson Deutschland GmbH & Co KGaA, an entity ultimately owned by the McKesson Corporation (‘McKesson’, United States) acquires certain businesses (‘the Target’) from UDG Healthcare plc (‘UDG’, Ireland), by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | McKesson operates in the distribution and delivery of: ethicals and branded pharmaceuticals and medical equipment; medical supply products; and the delivery of healthcare information technology to healthcare organisations. |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

McKesson operates in the distribution and delivery of: ethicals and branded pharmaceuticals and medical equipment; medical supply products; and the delivery of healthcare information technology to healthcare organisations.

| — | UDG is a provider of sales and marketing services, wholesaling, medical equipment, packaging and specialist healthcare delivery services. |
| --- | --- |

—

UDG is a provider of sales and marketing services, wholesaling, medical equipment, packaging and specialist healthcare delivery services.

| — | The Target includes UDG’s pharmaceutical wholesaling business in Ireland and the UK (comprising the United Drug Supply Chain Services business and the United Drug Sangers business); TCP, a healthcare services provider in Ireland; and MASTA, a travel healthcare business in the UK. |
| --- | --- |

—

The Target includes UDG’s pharmaceutical wholesaling business in Ireland and the UK (comprising the United Drug Supply Chain Services business and the United Drug Sangers business); TCP, a healthcare services provider in Ireland; and MASTA, a travel healthcare business in the UK.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7818 — McKesson/UDG Healthcare (pharmaceutical wholesale and associated businesses), to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7818 — McKesson/UDG Healthcare (pharmaceutical wholesale and associated businesses), to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---